Literature DB >> 23321451

High-density lipoprotein subclasses and risk of stroke and its subtypes in Japanese population: the Circulatory Risk in Communities Study.

Choy-Lye Chei1, Kazumasa Yamagishi, Akihiko Kitamura, Masahiko Kiyama, Hironori Imano, Tetsuya Ohira, Renzhe Cui, Takeshi Tanigawa, Tomoko Sankai, Yoshinori Ishikawa, Shinichi Sato, Shinichi Hitsumoto, Hiroyasu Iso.   

Abstract

BACKGROUND AND
PURPOSE: High-density lipoprotein (HDL) cholesterol is an established protective factor for ischemic stroke. However, the contribution of HDL subclasses to stroke risk and its subtypes is uncertain.
METHODS: A prospective nested case-control study of 40- to 85-year-old Japanese was undertaken using frozen serum samples collected from 5280 men and 7524 women. They participated in cardiovascular risk surveys from 1985 to 1999 (1 community) and 1989 to 1998 (2 communities) under Circulatory Risk in Communities Study. HDL cholesterol subclasses were classified by high-performance liquid chromatography into 3 subgroups: S-HDL (very small or small HDL), M-HDL (medium HDL), and L-HDL (large or very large HDL) cholesterol. One control subject per case was matched by sex, age, community, serum storage year, and fasting status.
RESULTS: In 2005, we identified 241 strokes (155 ischemic and 86 hemorrhagic). S-HDL and M-HDL cholesterol levels were inversely associated with total stroke risk, ischemic stroke, specifically lacunar infarction, and hemorrhagic stroke. After adjustment for cardiovascular risk factors, these associations remained statistically significant. Multivariable conditional odds ratios (95% confidence interval) for 1 SD (0.12 mmol/L) increment of S-HDL cholesterol levels were 0.34 (0.23-0.52) for total stroke, 0.38 (0.23-0.63) for ischemic stroke, 0.33 (0.18-0.61) for lacunar infarction, 0.30 (0.14-0.65) for hemorrhagic stroke, and 0.30 (0.12-0.77) for intraparenchymal hemorrhage. The respective multivariable odds ratios for 1SD (0.10 mmol/L) increment of M-HDL cholesterol levels were 0.56 (0.41-0.75), 0.63 (0.45-0.88), 0.59 (0.40-0.87), 0.41 (0.21-0.80), and 0.38 (0.16-0.90). No associations were found between L-HDL cholesterol levels and risk of total stroke and its subtypes.
CONCLUSIONS: Small- to medium-sized HDL, not large HDL, cholesterol levels were inversely associated with total stroke risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23321451     DOI: 10.1161/STROKEAHA.112.674812

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Inverse Association Between HDL (High-Density Lipoprotein) Cholesterol and Stroke Risk Among Patients With Type 2 Diabetes Mellitus.

Authors:  Yun Shen; Lizheng Shi; Elizabeth Nauman; Peter T Katzmarzyk; Eboni G Price-Haywood; Alessandra N Bazzano; Somesh Nigam; Gang Hu
Journal:  Stroke       Date:  2019-02       Impact factor: 7.914

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  HDL (High-Density Lipoprotein) Subspecies, Prevalent Covert Brain Infarcts, and Incident Overt Ischemic Stroke: Cardiovascular Health Study.

Authors:  Manja Koch; Sarah A Aroner; Annette L Fitzpatrick; W T Longstreth; Jeremy D Furtado; Kenneth J Mukamal; Majken K Jensen
Journal:  Stroke       Date:  2021-10-14       Impact factor: 7.914

Review 4.  Crosstalk between neurological, cardiovascular, and lifestyle disorders: insulin and lipoproteins in the lead role.

Authors:  Richa Tyagi; Bhupesh Vaidya; Shyam Sunder Sharma
Journal:  Pharmacol Rep       Date:  2022-09-23       Impact factor: 3.919

Review 5.  Lipids and Cerebrovascular Disease: Research and Practice.

Authors:  Shadi Yaghi; Mitchell S V Elkind
Journal:  Stroke       Date:  2015-10-08       Impact factor: 7.914

6.  Paradoxical Elevation of High Density Lipoprotein Cholesterol in Association with Lacunar-Type Cerebral Infarction.

Authors:  Gui-Lin Meng; Yan Tan; Min Fang; Hong-Yan Yang; Xue-Yuan Liu; Yan-Xin Zhao
Journal:  Med Sci Monit       Date:  2015-06-29

7.  Particle number analysis of lipoprotein subclasses by gel permeation HPLC in patients with cholesteryl ester transfer protein deficiency.

Authors:  Takeshi Okada; Tohru Ohama; Mitsuyo Okazaki; Kotaro Kanno; Hibiki Matsuda; Masami Sairyo; Yinghong Zhu; Ayami Saga; Takuya Kobayashi; Daisaku Masuda; Masahiro Koseki; Makoto Nishida; Yasushi Sakata; Shizuya Yamashita
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

8.  The Circulatory Risk in Communities Study (CIRCS): A Long-Term Epidemiological Study for Lifestyle-Related Disease Among Japanese Men and Women Living in Communities.

Authors:  Kazumasa Yamagishi; Isao Muraki; Yasuhiko Kubota; Mina Hayama-Terada; Hironori Imano; Renzhe Cui; Mitsumasa Umesawa; Yuji Shimizu; Tomoko Sankai; Takeo Okada; Shinichi Sato; Akihiko Kitamura; Masahiko Kiyama; Hiroyasu Iso
Journal:  J Epidemiol       Date:  2018-12-22       Impact factor: 3.211

9.  Isolated low levels of high-density lipoprotein cholesterol and stroke incidence: JMS Cohort Study.

Authors:  Jun Watanabe; Eiichi Kakehi; Kazuhiko Kotani; Kazunori Kayaba; Yosikazu Nakamura; Shizukiyo Ishikawa
Journal:  J Clin Lab Anal       Date:  2019-11-19       Impact factor: 2.352

10.  Apolipoprotein C-III in the high-density lipoprotein proteome of cerebral lacunar infarction patients impairs its anti-inflammatory function.

Authors:  Pu Lv; Mingming Zhao; Yuanyuan Liu; Haiqiang Jin; Wei Cui; Chenghe Fan; Yuming Teng; Lemin Zheng; Yining Huang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.